Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
Some HCV medications associated with serious liver injury
- Author:
- Christopher Palmer
In many cases, the medications should never have been prescribed, according to the FDA.
News
Farxiga gets Fast Track status from FDA
- Author:
- Christopher Palmer
Development of dapagliflozin to focus on slowing progression in renal failure and preventing cardiovascular and...
News
Class I recall issued for Sapien 3 balloon
- Author:
- Christopher Palmer
Risks of serious injury or death have led to a correction recall including updated instructions in cases of balloon bursts.
News
FDA approves Wakix for excessive daytime sleepiness
- Author:
- Christopher Palmer
The efficacy of pitolisant (Wakix) was evaluated in a pair of multicenter, randomized, double-blind, placebo-controlled studies.
News
FCC backs designating 988 as suicide prevention hotline
- Author:
- Christopher Palmer
The report submitted to Congress says the new three-digit number “could be more effective” at prevention than the current 10-digit one.
News
FDA approves upadacitinib for rheumatoid arthritis
- Author:
- Christopher Palmer
Although now approved for moderately to severely active disease, the drug comes with a boxed warning, the most serious warning issued by the FDA...
News
Nebraska issues SUNucate-based guidance for schools
- Author:
- Christopher Palmer
Nebraska is the 24th state to move to lift bans that prevent children from having and using sunscreen at school without a physician’s note or...
News
Evinacumab shows promise for HoFH in top line results
- Author:
- Christopher Palmer
Reductions of LDL cholesterol were seen at 2 weeks and were maintained for the rest of the 24-week study period.
News
FDA update: Higher late mortality with paclitaxel-coated devices
- Author:
- Christopher Palmer
A new letter to health care providers describes an FDA panel’s conclusions, and actions the agency is taking...
News
FDA accepts dasotraline NDA for binge-eating disorder
- Author:
- Christopher Palmer
Dasotraline, a dopamine and norepinephrine reuptake inhibitor, demonstrated efficacy in two 12-week trials and one long-term safety study.
News
Pertussis: Comparison studies show DTwP more durable
- Author:
- Christopher Palmer
Direct comparison of such studies can be tricky, but these studies used similar procedures and were conducted by the same company with the same...
News
Pentavalent DTaP-Hb-Hib vaccine is found noninferior to comparator
- Author:
- Christopher Palmer
Diphtheria, tetanus, pertussis, HBV, and Haemophilus influenzae type b all contribute to morbidity and mortality in India, where the...
News
FDA approves rituximab biosimilar for cancer, autoimmune disorders
- Author:
- Christopher Palmer
The biosimilar is approved for certain cancers and autoimmune disorders, although, like its reference drug, it comes with a boxed warning from the...
News
Adjuvanted influenza vaccine appears safe for at-risk children
- Author:
- Christopher Palmer
The adjuvanted trivalent inactivated influenza vaccine also showed greater immunogenicity than did the nonadjuvanted vaccines.
News
New scale could measure vaccine hesitancy in developing countries
- Author:
- Christopher Palmer
The shorter, four-item subscale looks especially promising and could be particularly useful in areas with low literacy rates.